ReDO: nitroglycerin as an anti-cancer agent

Sukhatme, V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015). Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent. Ecancermedicalscience, 9, 568. doi:10.3332/ecancer.2015.568

Therapeutic effect of Cryoablation and Meriva in Breast Cancer

Chandra, D., Jahangir, A., Cornelis, F., Rombauts, K., Meheus, L., Jorcyk, C. L., & Gravekamp, C. (2015). Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer. Oncoimmunology, 5(1), e1049802. doi:10.1080/2162402X.2015.1049802

ReDO: itraconazole as an anti-cancer agent

Pantziarka, P., Sukhatme, V., Bouche, G., Meheus, L., & Sukhatme, V. P. (2015). Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent. Ecancermedicalscience, 9, 521. doi:10.3332/ecancer.2015.521

Phytochemical, Analytical and Preclinical Investigations on Plant Extracts as Potential Antitumoural Therapy

ReDO: clarithromycin as an anti-cancer agent

Van Nuffel, A. MT., Sukhatme, V., Pantziarka, P., Meheus, L., Sukhatme, V. P., & Bouche, G. (2015). Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent. Ecancermedicalscience, 9, 513. doi:10.3332/ecancer.2015.513

Repurposing in your medicine cabinet

Pantziarka, P., Bouche, G., Meheus, L., Sukhatme, V., & Sukhatme, V.P. (2015). Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy? Future Oncology,11(2), 181-184. doi:10.2217/fon.14.244

ReDO: cimetidine as an anti-cancer agent

Pantziarka, P., Bouche, G., Meheus, L., Sukhatme, V., & Sukhatme, V. P. (2014). Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent. Ecancermedicalscience, 8, 485. doi:10.3332/ecancer.2014.485

Inconsistencies and questionable reliability of Yamamoto's publication on GcMAF

Ugarte, A., Bouche, G., & Meheus, L. (2014). Inconsistencies and questionable reliability of the publication "immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF" by Yamamoto et al. Cancer Immunology Immunotherapy, 63(12), 1347-8. doi: 10.1007/s00262-014-1587-y